Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline | Zendy

Navneet Singh | Zendy; Sarah Temin | Zendy; Sherman Baker | Zendy; Elizabeth Blanchard | Zendy; Julie R. Brahmer | Zendy; Paul Celano | Zendy; Narjust Duma | Zendy; Peter Ellis | Zendy; Ivy B. Elkins | Zendy; Rami Y. Haddad | Zendy; Paul J. Hesketh | Zendy; Dharamvir Jain | Zendy; David H. Johnson | Zendy; Natasha B. Leighl | Zendy; Hirva Mamdani | Zendy; Gregory A. Masters | Zendy; Pamela R. Moffitt | Zendy; Tanyanika Phillips | Zendy; Gregory J. Riely | Zendy; Andrew Robinson | Zendy; Rafael Rosell | Zendy; Joan H. Schiller | Zendy; Bryan J. Schneider | Zendy; David R. Spigel | Zendy; Ishmael Jaiyesimi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

Author(s) -

Navneet Singh,

Sarah Temin,

Sherman Baker,

Elizabeth Blanchard,

Julie R. Brahmer,

Paul Celano,

Narjust Duma,

Peter Ellis,

Ivy B. Elkins,

Rami Y. Haddad,

Paul J. Hesketh,

Dharamvir Jain,

David H. Johnson,

Natasha B. Leighl,

Hirva Mamdani,

Gregory A. Masters,

Pamela R. Moffitt,

Tanyanika Phillips,

Gregory J. Riely,

Andrew Robinson,

Rafael Rosell,

Joan H. Schiller,

Bryan J. Schneider,

David R. Spigel,

Ishmael Jaiyesimi

Publication year - 2022

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.22.00824

Subject(s) - medicine , crizotinib , guideline , anaplastic lymphoma kinase , ceritinib , alectinib , lung cancer , oncology , intensive care medicine , clinical trial , pathology , malignant pleural effusion

To provide evidence-based recommendations updating the 2021 ASCO and Ontario Health (Cancer Care Ontario) guideline on systemic therapy for patients with stage IV non-small-cell lung cancer (NSCLC) with driver alterations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research